Victor J. Dzau, M.D. Independent Director since 2000 Dr. Dzau is the chancellor for health affairs at Duke University and president and CEO of the Duke University Health System. He was previously the Hersey Professor of the theory and practice of medicine at Harvard Medical School and chairman of the department of medicine, physician-in-chief and director of research at Brigham and Women's Hospital in Boston. Prior to this, Dr. Dzau was the Arthur L. Bloomfield Professor and chairman of the department of medicine at Stanford University.

Dr. Dzau is a founding member of the Executive Committee of The Academy at Harvard Medical School. He has been elected to the Institute of Medicine, the National Academy of Science, and the European Academy of Science and Arts. Dr. Dzau was previously chairman of the National Institutes of Health Cardiovascular Disease Advisory Committee and also sat on the Advisory Committee to the Director of the NIH. He also sits on the board of directors of PepsiCo, Inc., Alnylam Inc., Medtronic, Inc. and the Duke University Health System. He brings to the board extensive experience in the medical field, both in the hospital and academic research settings. As CEO of the Duke University Health System, Dr. Dzau has a deep understanding of health care providers and of physicians, who are key opinion leaders, customers, and partners to Genzyme in conducting clinical trials. Dr. Dzau earned an M.D. from McGill University in Montreal, and did his postgraduate training at Harvard Medical School.